{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:19:11Z","timestamp":1790687951657,"version":"4.1.0"},"reference-count":69,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Prostate cancer management has long been challenged by the limitations of traditional screening tools like PSA testing, which contribute to significant rates of overdiagnosis and overtreatment. While advanced imaging such as multiparametric MRI (mpMRI) has improved the diagnostic pathway, the integration of Artificial Intelligence (AI) is now catalyzing a paradigm shift across the entire continuum of care. This comprehensive review details the transformative role of AI in prostate cancer. In diagnostics, deep learning algorithms enhance the interpretation of mpMRI by improving lesion detection, segmentation, and risk stratification, thereby reducing unnecessary biopsies. In digital pathology, AI provides automated and consistent Gleason grading, minimizing inter-observer variability and refining prognostication. In the therapeutic domain, AI is crucial for personalizing treatment by streamlining radiotherapy planning through automated contouring, predicting patient outcomes and toxicity, and enabling the development of adaptive therapy strategies for advanced disease. Multimodal AI models that synthesize imaging, biomarker, and clinical data are creating robust predictive tools for superior clinical decision support. Despite formidable challenges related to prospective validation, data equity, and regulatory approval, AI is paving the way for a new standard of care characterized by greater precision, efficiency, and personalization.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1670671","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T06:31:01Z","timestamp":1764225061000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Utilization of artificial intelligence in prostate cancer detection: a comprehensive review of innovations in screening and diagnosis"],"prefix":"10.3389","volume":"16","author":[{"given":"Emad","family":"Rajih","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulaziz","family":"Bakhsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walaa M.","family":"Borhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed Awad M.","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834.l","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA: Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjonc-2023\u2212000039","article-title":"Screening for prostate cancer: evidence, ongoing trials, policies and knowledge gaps","volume":"2","author":"Bratt","year":"2023","journal-title":"BMJ Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/SMMD.20220020","article-title":"Nurturing the marriages of urinary liquid biopsies and nano\u2212diagnostics for precision urinalysis of prostate cancer","volume":"2","author":"Liao","year":"2023","journal-title":"Smart Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"197\u2212206","DOI":"10.1097\/CU9.0000000000000145","article-title":"Prostate cancer screening: continued controversies and novel biomarker advancements","volume":"16","author":"Tidd\u2212Johnson","year":"2022","journal-title":"Curr Urol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"14\u221218","DOI":"10.59298\/IAAJSR\/2024\/113.1418","article-title":"Advancements in non\u2212invasive imaging techniques for early detection of prostate disorders: a review","volume":"11","author":"Mwende","year":"2024","journal-title":"IAA J Sci Res"},{"key":"B6","doi-asserted-by":"publisher","first-page":"6821\u22126826","DOI":"10.2147\/CMAR.S257769","article-title":"The value of prostate\u2212specific antigen\u2013related indexes and imaging screening in the diagnosis of prostate cancer","volume":"12","author":"Bai","year":"2020","journal-title":"Cancer Manag Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13132283","article-title":"Up\u2212to\u2212date imaging and diagnostic techniques for prostate cancer: a literature review","volume":"13","author":"Zhu","year":"2023","journal-title":"Diagnostics"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2022-0354","article-title":"Prostate health index (PHI) as a reliable biomarker for prostate cancer: a systematic review and meta-analysis","volume":"60","author":"Agnello","year":"2022","journal-title":"Clin Chem Lab Med (CCLM)"},{"key":"B9","doi-asserted-by":"publisher","first-page":"425","DOI":"10.21037\/tau-23-80","article-title":"Comparisons of the diagnostic accuracy across prostate health index, prostate health index density, and percentage free prostate-specific antigen for clinically significant prostate cancer: a prospective diagnostic study","volume":"12","author":"Wu","year":"2023","journal-title":"Tran1sl Androl Urol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2020.02.032","article-title":"Concordance and performance of 4Kscore and SelectMDx for informing decision to perform prostate biopsy and detection of prostate cancer","volume":"141","author":"Wysock","year":"2020","journal-title":"Urology"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2022.114854","article-title":"Accurate diagnosis of prostate cancer with CRISPR-based nucleic acid test strip by simultaneously identifying PCA3 and KLK3 genes","volume":"220","author":"Chen","year":"2023","journal-title":"Biosensors Bioelectron"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2023.10.029","article-title":"Diagnostic accuracy of liquid biomarkers for clinically significant prostate cancer detection: a systematic review and diagnostic meta-analysis of multiple thresholds","volume":"7","author":"Kawada","year":"2024","journal-title":"Eur Urol Oncol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"479\u2212484","DOI":"10.17762\/ijritcc.v11i8.9438","article-title":"Advancements in prostate cancer imaging: implications for diagnosis and treatment","volume":"11","author":"Jadhav","year":"2023","journal-title":"Int J Recent Innov Trends Comput Commun"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.3390\/cancers15153839","article-title":"Advancements in mri-based radiomics and artificial intelligence for prostate cancer: A comprehensive review and future prospects","volume":"15","author":"Chaddad","year":"2023","journal-title":"Cancers"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13213350","article-title":"Biomarkers for prostate cancer: from diagnosis to treatment","volume":"13","author":"Chen","year":"2023","journal-title":"Diagnostics"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.15672","article-title":"AI-assisted vs unassisted identification of prostate cancer in magnetic resonance images","volume":"8","author":"Twilt","year":"2025","journal-title":"JAMA Network Open"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20210633","article-title":"Multiparametric ultrasound and micro\u2212ultrasound in prostate cancer: a comprehensive review","volume":"95","author":"Dias","year":"2022","journal-title":"Br J Radiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"661\u2212676","DOI":"10.1007\/s00345\u2212020\u221203193\u22120","article-title":"Advanced ultrasound in the diagnosis of prostate cancer","volume":"39","author":"Correas","year":"2021","journal-title":"World J Urol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/photonics11090872","article-title":"Advances in photoacoustic endoscopic imaging technology for prostate cancer detection","volume":"11","author":"Wei","year":"2024","journal-title":"Photonics"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1189370","article-title":"Research progress on deep learning in magnetic resonance imaging\u2212based diagnosis and treatment of prostate cancer: a review on the current status and perspectives","volume":"13","author":"He","year":"2023","journal-title":"Front Oncol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1527\u22121538","DOI":"10.1088\/0031\u22129155\/57\/6\/1527","article-title":"Automatic computer\u2212aided detection of prostate cancer based on multiparametric magnetic resonance image analysis","volume":"57","author":"Vos","year":"2012","journal-title":"Phys Med Biol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1097\/CU9.0000000000000271","article-title":"Computer-aided diagnosis based on 3D deep convolutional neural network system using novel 3D magnetic resonance imaging sequences for high-grade prostate cancer","volume":"19","author":"Oka","year":"2025","journal-title":"Curr Urol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.euros.2022.11.009","article-title":"Automated patient-level prostate cancer detection with quantitative diffusion magnetic resonance imaging","volume":"47","author":"Zhong","year":"2023","journal-title":"Eur Urol Open Sci"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.17650\/1726\u22129776\u22122024\u221220\u22122\u221235\u221243","article-title":"Artificial intelligence in diagnosis of prostate cancer using magnetic resonance imaging: new approach","volume":"20","author":"Aboyan","year":"2024","journal-title":"Cancer Urol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13040615","article-title":"Joint cancer segmentation and PI-RADS classification on multiparametric MRI using MiniSegCaps network","volume":"13","author":"Jiang","year":"2023","journal-title":"Diagnostics"},{"key":"B26","doi-asserted-by":"publisher","first-page":"534\u2212550","DOI":"10.17816\/DD626643","article-title":"Diagnostic accuracy of artificial intelligence for the screening of prostate cancer in biparametric magnetic resonance imaging: a systematic review","volume":"5","author":"Kryuchkova","year":"2024","journal-title":"Digit Diagn"},{"key":"B27","doi-asserted-by":"publisher","first-page":"3833\u22123848","DOI":"10.1088\/0031\u22129155\/57\/12\/3833","article-title":"Computer\u2212aided diagnosis of prostate cancer in the peripheral zone using multiparametric MRI","volume":"57","author":"Niaf","year":"2012","journal-title":"Phys Med Biol"},{"key":"B28","first-page":"1","article-title":"Intelligent diagnosis of prostate tumors based on depth-wise separable convolutional neural network using transrectal ultrasound B-mode images","author":"Huang","year":"2024"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1097\/01.JU.0001008936.35187.0b.18","article-title":"MP31\u221218 artificial intelligence\u2212assisted prostate cancer detection on B\u2212mode transrectal ultrasound images","volume":"211","author":"Bhattacharya","year":"2024","journal-title":"J Urol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-023-00729-4","article-title":"Transperineal magnetic resonance imaging targeted biopsy versus transrectal route in the detection of prostate cancer: a systematic review and meta-analysis","volume":"27","author":"Wu","year":"2024","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20220238","article-title":"Radiomic\u2212based machine learning model for the accurate prediction of prostate cancer risk stratification","volume":"96","author":"Shu","year":"2023","journal-title":"Br J Radiol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16172944","article-title":"MRI T2w radiomics\u2212based machine learning models in imaging simulated biopsy add diagnostic value to PI\u2212RADS in predicting prostate cancer: a retrospective diagnostic study","volume":"16","author":"Liu","year":"2024","journal-title":"Cancers"},{"key":"B33","doi-asserted-by":"publisher","first-page":"3318","DOI":"10.3390\/jcm14103318","article-title":"The role of radiomics and artificial intelligence applied to staging PSMA PET in assessing prostate cancer aggressiveness","volume":"14","author":"Urso","year":"2025","journal-title":"J Clin Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"854\u2212860","DOI":"10.1097\/RLI.0000000000001102","article-title":"Multimodal AI combining clinical and imaging inputs improves prostate cancer detection","volume":"59","author":"Roest","year":"2024","journal-title":"Invest Radiol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2703\u22122715","DOI":"10.1007\/s11255\u2212023\u221203722\u2212x","article-title":"AI\u2212predicted mpMRI image features for the prediction of clinically significant prostate cancer","volume":"55","author":"Li","year":"2023","journal-title":"Int Urol Nephrol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"777\u2212785","DOI":"10.1097\/JU.0000000000004456","article-title":"An artificial intelligence model using diffusion basis spectrum imaging metrics accurately predicts clinically significant prostate cancer","volume":"213","author":"Kim","year":"2025","journal-title":"J Urol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s10916\u2212024\u221202118\u22123","article-title":"An artificial intelligent system for prostate cancer diagnosis in whole slide images","volume":"48","author":"Saha","year":"2024","journal-title":"J Med Syst"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2024.100564","article-title":"Enhancing prostate cancer diagnosis: artificial intelligence\u2212driven virtual biopsy for optimal MRI\u2212targeted biopsy approach and Gleason grading strategy","volume":"37","author":"Harder","year":"2024","journal-title":"Mod Pathol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14192127","article-title":"Artificial intelligence algorithms and their current role in the identification and comparison of Gleason patterns in prostate cancer histopathology: a comprehensive review","volume":"14","author":"Khalid","year":"2024","journal-title":"Diagnostics"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01620-2","article-title":"Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge","volume":"28","author":"Bulten","year":"2022","journal-title":"Nat Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"633\u2212642","DOI":"10.1016\/j.pathol.2024.02.009","article-title":"Validation of prostate and breast cancer detection artificial intelligence algorithms for accurate histopathological diagnosis and grading: a retrospective study with a Japanese cohort","volume":"56","author":"Lami","year":"2024","journal-title":"Pathology"},{"key":"B42","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13244\u2212024\u221201865\u22128","article-title":"Evaluating the feasibility of AI\u2212predicted bpMRI image features for predicting prostate cancer aggressiveness: a multi\u2212center study","volume":"16","author":"Wang","year":"2025","journal-title":"Insights Imag"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1177\/11795549241311408","article-title":"Adaptive treatment of metastatic prostate cancer using generative artificial intelligence","volume":"19","author":"Derbal","year":"2025","journal-title":"Clin Med Insights Oncol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15225452","article-title":"The development and external validation of artificial intelligence\u2212driven MRI\u2212based models to improve prediction of lesion\u2212specific extraprostatic extension in patients with prostate cancer","volume":"15","author":"Van den Berg","year":"2023","journal-title":"Cancers"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1158\/0008\u22125472.c.7267974.v1","article-title":"Data from mathematical model\u2212driven deep learning enables personalized adaptive therapy [dataset","volume":"84","author":"Gallagher","year":"2024","journal-title":"Am Assoc Cancer Res"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1929\u22121941","DOI":"10.1158\/0008\u22125472.CAN\u221223\u22122040","article-title":"Mathematical model\u2212driven deep learning enables personalized adaptive therapy","volume":"84","author":"Gallagher","year":"2024","journal-title":"Cancer Res"},{"key":"B47","doi-asserted-by":"publisher","first-page":"324\u2212340","DOI":"10.1038\/s41568\u2212025\u221200796\u2212w","article-title":"Using mathematical modelling and AI to improve delivery and efficacy of therapies in cancer","volume":"25","author":"Harkos","year":"2025","journal-title":"Nat Rev Cancer"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbae071","article-title":"Deep reinforcement learning identifies personalized intermittent androgen deprivation therapy for prostate cancer","volume":"25","author":"Lu","year":"2024","journal-title":"Brief Bioinform"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3390\/app13010325","article-title":"Multi\u2212objective deep reinforcement learning for personalized dose optimization based on multi\u2212indicator experience replay","volume":"13","author":"Huo","year":"2023","journal-title":"Appl Sci"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e1692\u2212e1700","DOI":"10.1093\/oncolo\/oyae184","article-title":"Artificial intelligence\u2212based personalized clinical decision\u2212making for patients with localized prostate cancer: surgery versus radiotherapy","volume":"29","author":"Liu","year":"2024","journal-title":"Oncol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"3755\u22123766","DOI":"10.1111\/cas.16327","article-title":"Prostate cancer treatment recommendation study based on machine learning and SHAP interpreter","volume":"115","author":"Tang","year":"2024","journal-title":"Cancer Sci"},{"key":"B52","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41746\u2212022\u221200613\u2212w","article-title":"Prostate cancer therapy personalization via multi\u2212modal deep learning on randomized phase III clinical trials","volume":"5","author":"Esteva","year":"2022","journal-title":"NPJ Digit Med"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2022.40.6_suppl.222","article-title":"Development and validation of a prognostic AI biomarker using multi\u2212modal deep learning with digital histopathology in localized prostate cancer on NRG Oncology phase III clinical trials","volume":"40","author":"Esteva","year":"2022","journal-title":"J Clin Oncol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1101\/2024.11.17.24317411","article-title":"AI-Powered cellular morphometric biomarkers discovered in needle biopsy of prostatic cancer predict neoadjuvant androgen deprivation therapy response and prognosis: an international multicenter retrospective study2","volume":"18","author":"Yan","year":"2024","journal-title":"medRxiv"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.5001","article-title":"Development and validation of an AI\u2212derived digital pathology\u2212based biomarker to predict benefit of long\u2212term androgen deprivation therapy with radiotherapy in men with localized high\u2212risk prostate cancer across multiple phase III NRG\/RTOG3 trials","volume":"41","author":"Armstrong","year":"2023","journal-title":"J Clin Oncol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2021.6871","article-title":"Interplay between duration of androgen deprivation therapy and external beam radiotherapy with or without a brachytherapy boost for optimal treatment of high\u2212risk prostate cancer: a patient\u2212level data analysis o4f three cohorts","volume":"8","author":"Kishan","year":"2022","journal-title":"JAMA Oncol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2300023","article-title":"Artificial intelligence predictive model for hormone therapy use in prostate cancer","volume":"2","author":"Spratt","year":"2023","journal-title":"NEJM Evid"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.phro.2023.100501","article-title":"Real\u2212world validation of artificial intelligence\u2212based computed tomography auto\u2212contouring for prostate cancer radiotherapy planning","volume":"28","author":"Palazzo","year":"2023","journal-title":"Phys Imaging Radiat Oncol"},{"key":"B59","first-page":"1\u221229","article-title":"Artificial intelligence in prostate cancer treatment with image\u2212guided radiation therapy","volume-title":"Artificial intelligence in cancer diagnosis and prognosis","author":"Yuan","year":"2022"},{"key":"B60","doi-asserted-by":"publisher","first-page":"103339","DOI":"10.1016\/j.ejmp.2024.103339","article-title":"Novel dosimetric validation of a commercial CT scanner based deep learning automated contour solution for prostate radiotherapy","volume":"122","author":"Berenato","year":"2024","journal-title":"Phys Medi"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3390\/app142310947","article-title":"Artificial intelligence and statistical models for the prediction of radiotherapy toxicity in prostate cancer: a systematic review","volume":"14","author":"Piras","year":"2024","journal-title":"Appl Sci"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1002\/bco2.456","article-title":"Focal therapy of prostate cancer: use of artificial intelligence to define tumour volume and predict treatment outcomes","volume":"6","author":"Brisbane","year":"2025","journal-title":"BJUI Compass"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.240041","article-title":"AI\u2212derived tumour volume from multiparametric MRI and outcomes in localized prostate cancer","volume":"313","author":"Yang","year":"2024","journal-title":"Radiology"},{"key":"B64","doi-asserted-by":"publisher","first-page":"367\u2212372","DOI":"10.12455\/j.issn.1671\u22127104.230557","article-title":"Research progress of artificial intelligence in prostate cancer diagnosis application","volume":"48","author":"Hong","year":"2024","journal-title":"Chin J Med Instrum"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16101809","article-title":"Catalyzing precision medicine: artificial intelligence advancements in prostate cancer diagnosis and management","volume":"16","author":"Talyshinskii","year":"2024","journal-title":"Cancers"},{"key":"B66","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1148\/radiol.2020192224","article-title":"Preparing medical imaging data for machine learning","volume":"295","author":"Willemink","year":"2020","journal-title":"Radiology"},{"key":"B67","doi-asserted-by":"publisher","first-page":"102470","DOI":"10.1016\/j.media.2022.102470","article-title":"Explainable artificial intelligence (XAI) in deep learning-based medical image analysis","volume":"79","author":"Van der Velden","year":"2022","journal-title":"Med image anal"},{"key":"B68","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12911-023-02103-9","article-title":"Ethics and governance of trustworthy medical artificial intelligence","volume":"23","author":"Zhang","year":"2023","journal-title":"BMC Med Inf Dec Mak"},{"key":"B69","doi-asserted-by":"publisher","first-page":"879\u2212887","DOI":"10.1016\/S1470\u22122045(24)00220\u22121","article-title":"Artificial intelligence and radiologists in prostate cancer detection on MRI (PI\u2212CAI): an international, paired, non\u2212inferiority, confirmatory study","volume":"25","author":"Saha","year":"2024","journal-title":"Lancet Oncol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1670671\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T06:31:05Z","timestamp":1764225065000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1670671\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":69,"alternative-id":["10.3389\/fimmu.2025.1670671"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1670671","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"article-number":"1670671"}}